High-dose IV vitamin C may lower risks of death and sepsis in trauma patients
· Medical Xpressedited by Sadie Harley, reviewed by Andrew Zinin
Sadie Harley
Scientific Editor
Meet our editorial team
Behind our editorial process
Andrew Zinin
Chief Editor
Meet our editorial team
Behind our editorial process Editors' notes
This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:
fact-checked
trusted source
proofread
The GIST Add as preferred source
High doses of intravenous (IV) vitamin C may lower the risk of death and sepsis in trauma patients, as well as shorten hospital stays, a review of the available evidence published online in the journal BMJ Military Health suggests.
Although its effects are biologically plausible, especially given its role in aiding tissue repair and recovery, among other things, the quality of the available evidence isn't currently good enough to recommend the use of vitamin C in trauma patients, the researchers say.
Major trauma triggers a complex physiological response in those affected and carries a high risk of death. Vitamin C, which helps boost blood pressure, regulate the vital interface between blood and tissues (endothelial function), and neutralize harmful free radicals, is rapidly depleted in critical illness, the researchers explain.
As such, vitamin C has been mooted as a potentially promising treatment to aid the recovery of trauma patients, including in the context of the war in Ukraine. But this approach has yet to be rigorously reviewed or formally implemented, they add.
In a bid to extend the evidence base, the researchers scoured research databases for relevant published studies on high-dose IV vitamin C, published up to the end of 2025.
They focused on its impact on death within 30 days of hospital discharge; prognostic scoring systems (Apache II, SOFA); incidence of complications, including sepsis and organ failure; and length of hospital stay.
Out of an initial haul of 108 studies, six, involving a total of 5,171 patients, were eligible for systematic review. Three studies were randomized controlled clinical trials; three were observational studies.
The studies reported a significant reduction in 30-day mortality, with significantly shorter intensive care unit and hospital stays. Four studies showed lower rates of sepsis in patients receiving vitamin C; two found lower rates of multi-organ failure.
"Overall, our findings demonstrate evidence of possible benefit in using high-dose vitamin C in the management of trauma patients," but the variation in the reported effects "suggests that treatment effects may be context-dependent rather than generalizable across all critical illnesses," the researchers write.
They also highlight several limitations to their findings: namely, the small number of studies, half of which were observational, and differences in patient groups, methodology, dosing regimens, co-interventions and outcome reporting.
"As our included studies did not use IV vitamin C monotherapy, we cannot truly associate our results with vitamin C alone. No studies investigated the timing of vitamin C, and therefore the optimal timing to administer vitamin C remains unclear.
"These methodological constraints limit the ability to draw firm conclusions about the optimal treatment protocols to use the potential benefits of vitamin C and contribute to the low certainty of evidence identified in this review," they add.
But they suggest: "Even slight reductions in mortality, sepsis, organ failure or critical care requirement could be used to consider its use in current operational settings, providing a clear rationale for future trauma-specific research before clinical adoption."
More information
A systematic review on the role of high-dose vitamin C in trauma patients, BMJ Military Health (2026). DOI: 10.1136/military-2026-003285
Key medical concepts
Clinical categories
Critical care medicineCommon illnesses & Prevention Provided by British Medical Journal Who's behind this story?
Sadie Harley
BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →
Andrew Zinin
Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →
Citation: High-dose IV vitamin C may lower risks of death and sepsis in trauma patients (2026, June 30) retrieved 1 July 2026 from https://medicalxpress.com/news/2026-06-high-dose-iv-vitamin-death.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.